1 Department of Radiology, St Vincent's University Hospital, Elm Park, Dublin, Ireland.
2 Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
AJR Am J Roentgenol. 2018 Sep;211(3):470-484. doi: 10.2214/AJR.17.19425. Epub 2018 Jul 11.
The hallmarks of cancer are mechanisms that cells develop to undergo malignant transformation. The targeting of these hallmarks by newer cancer therapies results in new mechanisms of response, toxicity, and resistance. The purpose of this article is to review these hallmarks, their associated targeted therapies, imaging features of responses, and toxicities.
Ten hallmarks, among them proliferative signaling, angiogenesis, immune response, and genome instability, are reviewed. Molecular targeted therapies, including antiangiogenic factors and immune checkpoint inhibitors, target these hallmarks.
癌症的特征是细胞发生恶性转化所采用的机制。较新的癌症疗法针对这些特征,产生了新的反应、毒性和耐药机制。本文旨在回顾这些特征、相关的靶向治疗、反应的影像学特征和毒性。
本文回顾了其中的 10 个特征,包括增殖信号、血管生成、免疫反应和基因组不稳定性。分子靶向治疗,包括抗血管生成因子和免疫检查点抑制剂,靶向这些特征。